Gemcitabine
Administration
• Given intravenously (IV, meaning through the veins) at 7-day intervals, 2 weeks out of 3, which defines one cycle.
• Different delivery methods, including cannulas, central lines, PICC lines, or implantable ports, are tailored to individual patient needs.
• A chemotherapy nurse, specialized pharmacist, or oncologist will oversee the administration, often in combination with other cancer drugs.
• Before treatment , a blood sample is taken to ensure safe blood cell levels for chemotherapy.
• You may receive oral or IV drugs prior and after the infusion to prevent nausea.
• Imaging is usually repeated every 2-3 cycles to determine the response.
• The number of cycles of treatment will depend on your tolerance to treatment and your response.
Potential Side Effects & Management
While treatment is being given:
• Flu-like symptoms: Feeling hot, cold, or shivery; headache; aching. These symptoms may last few hours. If severe, contact the hospital.
• Breathlessness: Mild breathlessness after gemcitabine is common and usually improves on its own. Inform your nurse or doctor if you experience this.
Common Side Effects:
• Infection Risk: Given sarcoma treatments’ intensity, reduced white blood cell counts heighten infection risks, necessitating vigilance and timely medical intervention. If you have a fever over 38.3°C, you should advise your medical team or go to the emergency department.
• Bruising and Bleeding: Reduced platelets due to treatment can lead to easy bruising, nosebleeds, or blood in urine/stool. Platelet transfusion might be necessary.
• Anemia: Reduced red blood cells due to treatment can cause anemia. If severe, blood transfusion might be necessary.
• Nausea: Managing this side effect can significantly impact quality of life during treatment.
• Loss of Appetite: Treatment can impact appetite temporarily. Dietary changes may be suggested.
• Diarrhea: Increased bowel activity; more common if you have a stoma.
• Constipation: inability to pass stools as often as usual. Management includes drinking a lot of fluids, increasing fiber consumption, light exercise, and in severe cases, laxatives may be prescribed.
• Effects on Kidneys and Liver: Blood tests monitor kidney and liver function. Maintain hydration and report any unusual symptoms.
• Effects on the Lungs: Notify your doctor of any respiratory symptoms like coughing or breathlessness.
• Fluid build-up: Weight gain or swelling; improves after treatment.
• Sore Mouth & Throat: Treatment may cause sore mouth and throat which can potentially lead to mouth ulcers and increased risk of infection. Maintain oral hygiene; contact your healthcare team for mouthwash or medicines if needed.
• Skin Changes: Rash, sensitivity, discoloration; moisturizing and protective measures are recommended.
• Headache, Muscle or Joint Pain: Post-treatment pain in head, muscles or joints may arise; notify your doctor for pain relief, especially if persistent.
• Feeling tired and sleepy: Common towards the end of treatment; pace yourself. If you’re feeling drowsy, avoid driving or operating machinery.
Less Common Side Effects:
• Effects on the Brain: Gemcitabine treatment rarely poses a risk of posterior reversible encephalopathy syndrome (PRES), characterized by symptoms like persistent headache, drowsiness, confusion, visual changes, or seizures. Immediate medical attention is crucial, and a full recovery is possible with prompt diagnosis and treatment.
• Effects on the Heart: Regular heart function tests are conducted. Report chest pain, breathlessness, or dizziness to your doctor.
Precautionary Measures for Sarcoma Patients
• Blood clot risk: Report symptoms like swelling, breathlessness, or sharp chest pain immediately.
• Communication: Always prioritize informing your healthcare team about ongoing sarcoma treatments, ensuring coordinated care and potential adjustments.
• Vaccinations: Sarcoma patients should be aware of vaccination recommendations, especially considering treatment impacts on immune responses.
• Sex and Contraception: Gemcitabine may impact fertility; discuss and plan contraception strategies with your oncologists.
• Breastfeeding: Avoid while having treatment.
Understanding the details of this treatment, including its administration, potential side effects, and precautionary measures, empowers patients to actively participate in their care and optimize treatment outcomes. Always communicate openly with your healthcare team for personalized guidance and support.